PMID- 24632822 OWN - NLM STAT- MEDLINE DCOM- 20141228 LR - 20220419 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 9 IP - 3 DP - 2014 TI - Autoantibodies to agrin in myasthenia gravis patients. PG - e91816 LID - 10.1371/journal.pone.0091816 [doi] LID - e91816 AB - To determine if patients with myasthenia gravis (MG) have antibodies to agrin, a proteoglycan released by motor neurons and is critical for neuromuscular junction (NMJ) formation, we collected serum samples from 93 patients with MG with known status of antibodies to acetylcholine receptor (AChR), muscle specific kinase (MuSK) and lipoprotein-related 4 (LRP4) and samples from control subjects (healthy individuals and individuals with other diseases). Sera were assayed for antibodies to agrin. We found antibodies to agrin in 7 serum samples of MG patients. None of the 25 healthy controls and none of the 55 control neurological patients had agrin antibodies. Two of the four triple negative MG patients (i.e., no detectable AChR, MuSK or LRP4 antibodies, AChR-/MuSK-/LRP4-) had antibodies against agrin. In addition, agrin antibodies were detected in 5 out of 83 AChR+/MuSK-/LRP4- patients but were not found in the 6 patients with MuSK antibodies (AChR-/MuSK+/LRP4-). Sera from MG patients with agrin antibodies were able to recognize recombinant agrin in conditioned media and in transfected HEK293 cells. These sera also inhibited the agrin-induced MuSK phosphorylation and AChR clustering in muscle cells. Together, these observations indicate that agrin is another autoantigen in patients with MG and agrin autoantibodies may be pathogenic through inhibition of agrin/LRP4/MuSK signaling at the NMJ. FAU - Zhang, Bin AU - Zhang B AD - Department of Neuroscience and Regenerative Medicine and Department of Neurology, Medical College of Georgia, Georgia Regents University, Augusta, Georgia, United States of America; Department of Physiology, Basic Medical School, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, Hubei Province, P. R. China. FAU - Shen, Chengyong AU - Shen C AD - Department of Neuroscience and Regenerative Medicine and Department of Neurology, Medical College of Georgia, Georgia Regents University, Augusta, Georgia, United States of America; Charlie Norwood VA Medical Center, Augusta, Georgia, United States of America. FAU - Bealmear, Beverly AU - Bealmear B AD - Department of Neurology, School of Medicine, Wayne State University, Detroit, Michigan, United States of America. FAU - Ragheb, Samia AU - Ragheb S AD - Department of Neurology, School of Medicine, Wayne State University, Detroit, Michigan, United States of America; Department of Biomedical Sciences, Oakland University William Beaumont School of Medicine, Rochester, Michigan, United States of America. FAU - Xiong, Wen-Cheng AU - Xiong WC AD - Department of Neuroscience and Regenerative Medicine and Department of Neurology, Medical College of Georgia, Georgia Regents University, Augusta, Georgia, United States of America; Charlie Norwood VA Medical Center, Augusta, Georgia, United States of America. FAU - Lewis, Richard A AU - Lewis RA AD - Department of Neurology, School of Medicine, Wayne State University, Detroit, Michigan, United States of America; Department of Neurology, Cedars-Sinai Medical Center, West Hollywood, California, United States of America. FAU - Lisak, Robert P AU - Lisak RP AD - Department of Neurology, School of Medicine, Wayne State University, Detroit, Michigan, United States of America; Department of Immunology and Microbiology, School of Medicine, Wayne State University, Detroit, Michigan, United States of America. FAU - Mei, Lin AU - Mei L AD - Department of Neuroscience and Regenerative Medicine and Department of Neurology, Medical College of Georgia, Georgia Regents University, Augusta, Georgia, United States of America; Charlie Norwood VA Medical Center, Augusta, Georgia, United States of America. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140314 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (Agrin) RN - 0 (Autoantibodies) RN - 0 (Autoantigens) RN - 0 (Receptors, Cholinergic) RN - EC 2.7.10.1 (MUSK protein, human) RN - EC 2.7.10.1 (Receptor Protein-Tyrosine Kinases) SB - IM MH - Agrin/*immunology MH - Autoantibodies/blood/*immunology MH - Autoantigens/immunology MH - Humans MH - Myasthenia Gravis/*immunology/metabolism MH - Phosphorylation MH - Protein Binding MH - Receptor Protein-Tyrosine Kinases/metabolism MH - Receptors, Cholinergic/immunology/metabolism PMC - PMC3954737 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2014/03/19 06:00 MHDA- 2014/12/30 06:00 PMCR- 2014/03/14 CRDT- 2014/03/18 06:00 PHST- 2014/01/23 00:00 [received] PHST- 2014/02/02 00:00 [accepted] PHST- 2014/03/18 06:00 [entrez] PHST- 2014/03/19 06:00 [pubmed] PHST- 2014/12/30 06:00 [medline] PHST- 2014/03/14 00:00 [pmc-release] AID - PONE-D-14-01782 [pii] AID - 10.1371/journal.pone.0091816 [doi] PST - epublish SO - PLoS One. 2014 Mar 14;9(3):e91816. doi: 10.1371/journal.pone.0091816. eCollection 2014.